Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea
- PMID: 414510
- DOI: 10.3109/00016347709154988
Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea
Abstract
Sixty women were given intravenous injection of 200 microgram TRH to assess its diagnostic potential as a stimulus to PRL release. Following the administration of TRH, there was a prompt increase in serum PRL to 614.6%, to 296%, to 282.1%, and 34% in normal women, amenorrheic patients, non tumoral galactorrheic cases, and patients with pituitary tumors respectively. The TRH response above baseline of PRL levels was statistically significant in all groups, but the women with pituitary tumors which showed a blunted response. The per cent of increment of PRL levels after TRH was similar in amenorrheic women regardless the presence or not of galactorrhea; this increase was significantly greater than in patients with pituitary tumors (p less than 0.01). The per cent of increment above baseline of PRL was significantly greater in menstruating women than in amenorrheic patients (p less than 0.001). In basis of present data: 1) there is a diminished PRL secretion after TRH in amenorrheic women regardless the presence of galactorrhea or hyperprolactinemia; 2) a blunted response to TRH in hyperprolactinemic women may be indicative of a pituitary tumor.
PIP: 60 women were given 200 mcg thyrotropin releasing hormone (TRH) iv to assess its stimulus to prolactin (PRL) release as a diagnostic tool. It has been suggested that a blunted response to TRH in hyperprolactinemic women may be indicative of a pituitary tumor. The group included 6 normal women, 18 with hypothalamic amenorrhea, 31 with idiopathic amenorrhea galactorrhea, and 11 with pituitary tumor. Following TRH administration, serum PRL increased 614.6% in normal women, 296% in the amenorrheic, 282.1% in the nontumoral galactorrheic, and 34% in the patients with pituitary tumors. TRH response above baseline PRL levels was significant (p .001) in all but the tumor patients. Increase above baseline PRL was also greater in menstruating women than in amenorrheic (p .001). It is suggested that there is diminished PRL secretion after TRH in amenorrheic women regardless of the presence of galactorrhea or hyperprolactinemia and that a blunted response may be helpful in separating patients with pituitary tumor from those with galactorrhea of other causes.
Similar articles
-
The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.Am J Obstet Gynecol. 1978 Apr 15;130(8):894-904. doi: 10.1016/0002-9378(78)90266-1. Am J Obstet Gynecol. 1978. PMID: 565142
-
Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome.J Clin Endocrinol Metab. 1980 Nov;51(5):968-71. doi: 10.1210/jcem-51-5-968. J Clin Endocrinol Metab. 1980. PMID: 6775003
-
Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.J Clin Endocrinol Metab. 1977 May;44(5):809-19. doi: 10.1210/jcem-44-5-809. J Clin Endocrinol Metab. 1977. PMID: 404308
-
Galactorrhea and hyperprolactinemia.Obstet Gynecol Surv. 1983 Dec;38(12):689-700. doi: 10.1097/00006254-198312000-00001. Obstet Gynecol Surv. 1983. PMID: 6361641 Review.
-
Hyperprolactinemia and hypogonadism in the human female.Eur J Obstet Gynecol Reprod Biol. 1977;7(5):337-48. doi: 10.1016/0028-2243(77)90019-3. Eur J Obstet Gynecol Reprod Biol. 1977. PMID: 400856 Review.
Cited by
-
More on nomifensine.J Endocrinol Invest. 1985 Oct;8(5):487. doi: 10.1007/BF03348543. J Endocrinol Invest. 1985. PMID: 4078245 No abstract available.
-
Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.J Endocrinol Invest. 1984 Apr;7(2):137-40. doi: 10.1007/BF03348404. J Endocrinol Invest. 1984. PMID: 6725869
-
Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):515-8. doi: 10.1136/bmj.288.6416.515. Br Med J (Clin Res Ed). 1984. PMID: 6421360 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources